Bdk Pharma Private Limited - Company Profile

It is a business services private limited company based in Chennai, Tamil Nadu, India, established in 2023.
2023 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Bdk Pharma Private Limited

Bdk Pharma Private Limited, a active private limited company, was established on 05 September 2023 in Chennai, Tamil Nadu, India. it holds CIN: U47721TN2023PTC163430. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ershad Ahamed (Director), Ahmed Lafir Habib (Director), Ahamed Faris Noohumohamedameerfizel (Director). Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Suit No.5, 8Th Floor, Door No. 1A,, Jhaver Plaza, Nungambakkam High Road,, Chennai, Tamil Nadu, 600034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47721TN2023PTC163430

  • Registration Number

    163430

  • Incorporation Date

    05 September 2023

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Bdk Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bdk Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bdk Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Ershad Ahamed Director 05 Sep 2023 Current
Ahmed Lafir Habib Director 30 Jul 2024 Current
Ahamed Faris Noohumohamedameerfizel Director 05 Sep 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bdk Pharma.

Enhance accessibility to Bdk Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Bdk Pharma revenue growth over time
Bdk Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bdk Pharma?

Unlock access to Bdk Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bdk Pharma?

Unlock and access historical data on people associated with Bdk Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bdk Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bdk Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bdk Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Bdk Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Bdk Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.

  • Director Appointment

    Progress on Ahmed Lafir Habib was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 1 year 7 months . was documented.

  • Director Appointment

    The activity Ershad Ahamed was appointed as a Director was appointed as a Director on 05 Sep 2023 & has been associated with this company since 2 years 5 months . was completed.

  • Director Appointment

    Ahamed Faris Noohumohamedameerfizel was appointed as a Director was appointed as a Director on 05 Sep 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Bdk Pharma Private Limited was registered on 05 Sep 2023 with Roc Chennai & aged 2 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bdk Pharma Private Limited?

The CIN of Bdk Pharma Private Limited is U47721TN2023PTC163430.

Where is Bdk Pharma Private Limited headquartered?

Bdk Pharma Private Limited is headquartered at Suit No.5, 8Th Floor, Door No. 1A,, Jhaver Plaza, Nungambakkam High Road,, Chennai, Tamil Nadu, 600034.

When was Bdk Pharma Private Limited incorporated?

Bdk Pharma Private Limited was incorporated on 05 September 2023.

Who are the current directors of Bdk Pharma Private Limited?

The current directors of Bdk Pharma Private Limited are

Is Bdk Pharma Private Limited a listed company?

Bdk Pharma Private Limited is unlisted.

What is the capital structure of Bdk Pharma Private Limited?

The authorized capital of Bdk Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available